In this comparison I examine two small-cap companies operating at the edges of the U.S. cannabis economy: MAPS, the parent of the Weedmaps marketplace, and SHFS, a provider of banking and lending services to financial institutions serving cannabis businesses. Although both names are tied to the same broad sector, their market positioning, financial health, and recent price behavior have diverged considerably. Investors who follow high-risk, high-volatility micro-cap equities—or who track the evolving cannabis-finance landscape—may find this relative-performance analysis useful when evaluating which business currently demonstrates the stronger operational footing.
MAPS represents WM Technology, Inc., best known for its Weedmaps consumer marketplace and a suite of commerce, advertising, and compliance software tools for cannabis retailers and brands. The company reported fourth-quarter 2025 revenue of $43.1 million and full-year 2025 revenue of $174.7 million, sustaining consecutive quarters of positive adjusted EBITDA and achieving full-year net income profitability. Recent weeks have also brought board refreshments and governance updates as management works to stabilize the business. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
A notable development is the company’s decision to voluntarily delist its Class A common stock from Nasdaq, with trading moving to the over-the-counter market. This shift reflects both the company’s micro-cap scale and its effort to reduce exchange-related compliance burdens. While the move reduces institutional visibility and can dampen liquidity, the underlying business has shown improving profitability, which has helped support sentiment among investors focused on fundamentals rather than exchange listing status.
SHFS is SHF Holdings, Inc., commonly known as Safe Harbor Financial. Founded in 2015 and headquartered in Golden, Colorado, the company provides access to banking, lending, cash management, and regulatory compliance services for financial institutions serving the cannabis industry. Its revenue has contracted meaningfully, with fiscal 2025 revenue of roughly $7.4 million, down more than 50% year over year, alongside persistent net losses on a trailing basis.
The stock’s recent price action reflects severe distress. Over the past year, SHFS has fallen from a 52-week high above $30 to a fraction of a dollar, a decline of more than 99%, a move amplified by share-count changes and heavy dilution. With a market capitalization measured in the low single-digit millions and minimal institutional ownership, liquidity and volatility are pronounced. Sentiment has been pressured by revenue declines, ongoing losses, and uncertainty about the company’s ability to regain financial scale.
The two companies sit in different layers of the cannabis value chain. MAPS is a technology and marketplace business with recurring software and advertising revenue, a broader customer base, and evidence of improving profitability. SHFS is a niche financial-services intermediary whose revenue is more concentrated and has been shrinking. In terms of growth drivers, MAPS leans on marketplace scale and software adoption, while SHFS depends on lending volumes and banking partnerships that have yet to stabilize.
Risk profiles also differ. Both stocks face sector-level regulatory and legal uncertainty tied to federal cannabis policy, but SHFS carries additional balance-sheet and dilution risks after its extreme share-price decline. MAPS trades over the counter following its voluntary Nasdaq delisting, which limits liquidity and institutional participation. On market sentiment, MAPS has shown more constructive recent behavior tied to profitability milestones, whereas SHFS sentiment remains dominated by its sharp de-rating.
Weighing trend consistency, financial stability, and relative positioning, Tickeron’s AI currently favors MAPS over SHFS. The comparative edge rests on MAPS’s full-year profitability, steadier revenue base, and more orderly recent price structure, even with its over-the-counter listing. By contrast, SHFS exhibits weaker momentum, contracting revenue, and elevated dilution risk. This assessment reflects observable, probabilistic factors rather than a definitive forecast, and either name remains a high-risk micro-cap position. I’m watching this closely as new data emerges.
When I compare names like these, I often turn to Tickeron’s AI Daily Buy/Sell Signals for a quick read on momentum patterns. The platform lets me cross-check recent signals across similar micro-caps and see how automated strategies are positioned, which adds useful context to the fundamental picture without replacing my own analysis.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Experienced trader focused on market analysis, identifying trading opportunities, and developing custom trading signals based on market trends, price action, and data-driven insights. Join my Trader Club to follow my latest analysis, trading ideas, and active signals: https://tickeron.com/app/trader-club/103/view?tab=active§ion=trades&via=john
a blank check company, which intends to focus on businesses in the cannabis industry. The company was founded by Scott Gordon on June 7, 2019 and is headquartered in New York, NY
Industry PackagedSoftware